Nasdaq

Treace Medical Concepts Launches Limited Market Release of Percuplasty™ Percutaneous 3D Bunion Correction® System

Treace Medical Concepts, Inc. has announced the limited market release of its new Percuplasty™ Percutaneous 3D Bunion Correction® System, following successful initial surgical cases. This innovative ...
Nasdaq

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
FOX40 News

Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure

PONTE VEDRA, Fla., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Hosted on MSN

Treace Medical anticipates 7–10% revenue growth in 2025 while launching next-gen bunion solutions

Earnings Call Insights: Treace Medical Concepts, Inc. (TMCI) Q2 2025 John T. Treace, CEO, highlighted that "the second quarter in this transformational year for Treace demonstrates our commitment to ...
WGHP

Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures

Company Receives 510(k) Clearance for Second-Generation SpeedPlate™ Implant Fixation Platform Ahead of Full Market Launch in Fourth Quarter of 2023 PONTE VEDRA, Fla., Sept. 11, 2023 (GLOBE NEWSWIRE) - ...